{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T16:29:26Z","timestamp":1772641766150,"version":"3.50.1"},"reference-count":15,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.2169\/internalmedicine.3606-19","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T22:04:36Z","timestamp":1580508276000},"page":"1195-1198","source":"Crossref","is-referenced-by-count":14,"title":["Promising Effects of Benralizumab on Chronic Eosinophilic Pneumonia"],"prefix":"10.2169","volume":"59","author":[{"given":"Kohsuke","family":"Isomoto","sequence":"first","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"},{"name":"Department of Medical Oncology, Kindai University Faculty of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohisa","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akimasa","family":"Sekine","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoto","family":"Aiko","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ogura","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Carrington CB, Addington WW, Goff AM, et al. Chronic eosinophilic pneumonia. N Eng J Med 280: 787-798, 1969.","DOI":"10.1056\/NEJM196904102801501"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med 150: 1423-1438, 1994.","DOI":"10.1164\/ajrccm.150.5.7952571"},{"key":"3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1398-9995.2005.00812.x","volume":"60","author":"V Cottin","year":"2005","unstructured":"3. Cottin V, Cordier J-F. Eosinophilic pneumonias. Allergy 60: 841-857, 2005.","journal-title":"Allergy","ISSN":"https:\/\/id.crossref.org\/issn\/0105-4538","issn-type":"print"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Marchand E, Reynaud-Gaubert M, Lauque D, Durieu J, Tonnel AB, Cordier JF. The Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM "O" P) Idiopathic chronic eosinophilic pneumonia. A clinical and follow-up study of 62 cases. Medicine (Baltimore) 77: 299-312, 1998.","DOI":"10.1097\/00005792-199809000-00001"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Kolbeck R, Kozhich A, Koike M, et al. MEDI-563, a humanized anti-IL-5 receptor alpha mAb with enhanced antibody-dependent cell-mediated cytotoxicity function. J Allergy Clin Immunol 125: 1344-1353, 2010.","DOI":"10.1016\/j.jaci.2010.04.004"},{"key":"6","unstructured":"6. Bleecker ER, FitzGerald JM, Chanez P, et al. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting \u03b22-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial. Lancet 388: 2115-2127, 2016."},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Curtis JR, Westfall AO, Allison J, et al. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum 55: 420-426, 2006.","DOI":"10.1002\/art.21984"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kaya H, G\u00fcm\u00fc\u015f S, U\u00e7ar E, et al. Omalizumab as a steroid-sparing agent in chronic eosinophilic pneumonia. Chest 142: 513-516, 2012.","DOI":"10.1378\/chest.11-1881"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lin RY, Santiago TP, Patel NM. Favorable response to asthma-dosed subcutaneous mepolizumab in eosinophilic pneumonia. J Asthma 56: 1193-1197, 2019.","DOI":"10.1080\/02770903.2018.1534966"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. To M, Kono Y, Yamawaki S, et al. A case of chronic eosinophilic pneumonia successfully treated with mepolizumab. J Allergy Clin Immunol Pract 6: 1746-1748, 2018.","DOI":"10.1016\/j.jaip.2018.06.017"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Menzella F, Montanari G, Patricelli G, et al. A case of chronic eosinophilic pneumonia in a patient treated with dupilumab. Ther Clin Risk Manag 15: 869-875, 2019.","DOI":"10.2147\/TCRM.S207402"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Fulkerson PC, Rothenberg ME. Targeting eosinophils in allergy, inflammation and beyond. Nature Reviews Drug Discovery 12: 117-129, 2013.","DOI":"10.1038\/nrd3838"},{"key":"13","unstructured":"13. Yanagibashi T, Satoh M, Nagai Y, Koike M, Takatsu K. Allergic diseases: from bench to clinic - contribution of the discovery of interleukin-5. Cytokine 98: 59-70, 2017."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Busse WW, Katial R, Gossage D, et al. Safety profile, pharmacokinetics, and biologic activity of MEDI-563, an anti-IL-5 receptor alpha antibody, in a phase I study of subjects with mild asthma. J Allergy Clin Immunol 125: 1237-1244, 2010.","DOI":"10.1016\/j.jaci.2010.04.005"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Laviolette M, Gossage DL, Gauvreau G, et al. Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia. J Allergy Clin Immunol 132: 1086-1096, 2013.","DOI":"10.1016\/j.jaci.2013.05.020"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/9\/59_3606-19\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T06:00:50Z","timestamp":1614232850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/59\/9\/59_3606-19\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":15,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.3606-19","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}